Helping adults with HIV who drink too much in Zambia and Alabama
Zambia Alabama HIV Alcohol Comorbidities Program (ZAMBAMA)
This program offers counseling to help adults with HIV who drink too much cut back on alcohol and stay on their HIV treatment in clinics in Zambia and Alabama.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-11419505 on NIH RePORTER |
What this research studies
You would join if you are an adult (21+) with HIV who drinks more than is healthy and receive care at a participating clinic. Participants in two randomized trials will be offered a counseling program called CETA or the usual clinic care, and staff will track alcohol use, medication adherence, and HIV viral load over time. The team will study which parts of the counseling help, whether it works differently for people with other health or mental health issues or by sex, and how results compare between Zambia and Alabama. The project will also measure costs and practical steps needed to make this counseling part of routine HIV care.
Who could benefit from this research
Good fit: Adults aged 21 and older with HIV who report unhealthy alcohol use and receive care at participating HIV clinics in Zambia or Alabama are the intended candidates.
Not a fit: People without HIV, those who do not have unhealthy alcohol use, minors under 21, or patients receiving care outside the participating clinic sites are unlikely to be eligible or directly benefit.
Why it matters
Potential benefit: If successful, this could help people with HIV drink less, take their HIV medicines more consistently, and achieve better viral control.
How similar studies have performed: CETA and other transdiagnostic counseling approaches have reduced substance use and improved mental health in prior trials, but applying CETA specifically to improve HIV outcomes across different countries is a newer step.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Cropsey, Karen L — University of Alabama at Birmingham
- Study coordinator: Cropsey, Karen L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.